Hypertension Drugs Market size was valued at USD 21.85 billion in 2024 and is expected to cross USD 37.11 billion by the end of 2037, registering more than 4.3% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of hypertension drugs is estimated at USD 22.58 billion.
The market is expanding due to an increase in hypertension cases around the world, as it is a condition caused by chronic kidney infection, apnea, and other factors, and is the most common health disorder among the majority of the global population. As a result, the high demand for hypertension drugs is attributed to the high sales volume of hypertension drugs and their available treatment options.
The growing prevalence of insomnia across the globe is believed to fuel market growth. For instance, insomnia is a common sleep disorder that makes it difficult to fall asleep or sometimes causes a person to wake up early. Insomnia is noticed to be interlinked with hypertension and beta-blockers are highly used to treat insomnia heavily across the globe. For instance, it was stated that in every 3 adults across the globe, one of them has insomnia.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?